We are live on !
Find out more
PM
Parametrica Management Portfolio holdings
AUM
$142M
Turnover
60%
1-Year Est. Return
113.92%
This Fund
S&P 500
This Quarter Est. Return
+0.49%
1 Year Est. Return
+113.92%
3 Year Est. Return
+543.23%
5 Year Est. Return
+714.65%
10 Year Est. Return
–
AUM
$48.9M
AUM Growth
-$42.9M
(-47%)
Cap. Flow
-$39.6M
Cap. Flow % of AUM
Cap. Flow %
-81.01%
Top 10 Holdings %
Top 10 Hldgs %
55.14%
Holding
193
New
27
Increased
13
Reduced
23
Closed
127
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$3.66M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$2.64M |
| 3 |
Wolfspeed
WOLF
|
+$1.19M |
| 4 |
Microsoft
MSFT
|
+$939K |
| 5 |
10x Genomics
TXG
|
+$807K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$4.3M |
| 2 |
Li Auto
LI
|
+$2.35M |
| 3 |
JD.com
JD
|
+$1.63M |
| 4 |
Hertz
HTZ
|
+$1.59M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$1.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.42% |
| 2 | Healthcare | 20.81% |
| 3 | Miscellaneous | 17.95% |
| 4 | Communication Services | 13.78% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Alphabet (Google) Class A
GOOGL
$3.44T
| $4.92M | 10.06% |
51,435
-265
| -0.5% | -$29.4K |
2021 Q1
6 quarters
|
|
2
State Street Industrial Select Sector SPDR ETF
XLI
$30.8B
| $3.47M | 7.08% |
41,800
| – | – |
2021 Q3
4 quarters
|
|
|
3
iShares Biotechnology ETF
IBB
$11.3B
| $3.46M | 7.06% |
+29,500
| New | +$3.66M |
2022 Q3
0 quarters
|
|
|
4
Alnylam Pharmaceuticals
ALNY
$22.1B
| $2.77M | 5.66% |
+13,839
| New | +$2.64M |
2022 Q3
0 quarters
|
|
|
5
Microsoft
MSFT
$3.88T
| $2.58M | 5.26% |
11,065
+3,556
| +47% | +$939K |
2021 Q1
6 quarters
|
|
|
6
Wolfspeed
WOLF
$1.16B
| $2.52M | 5.15% |
24,352
+12,392
| +104% | +$1.19M |
2022 Q1
2 quarters
|
|
|
7
Hertz
HTZ
$684M
| $2.07M | 4.23% |
127,114
-84,729
| -40% | -$1.59M |
2022 Q1
2 quarters
|
|
8
State Street SPDR S&P Biotech ETF
XBI
$10.8B
| $1.86M | 3.81% |
23,500
-12,300
| -34% | -$1.04M |
2022 Q1
2 quarters
|
|
9
Southwest Airlines
LUV
$20.8B
| $1.75M | 3.57% |
56,593
-27,310
| -33% | -$1.02M |
2021 Q2
5 quarters
|
|
10
Eli Lilly
LLY
$1.26T
| $1.59M | 3.25% |
4,917
-641
| -12% | -$203K |
2022 Q2
1 quarter
|
|
11
Tesla
TSLA
$1.58T
| $1.23M | 2.51% |
4,639
-1,547
| -25% | -$432K |
2022 Q2
1 quarter
|
|
|
12
10x Genomics
TXG
$9.13B
| $992K | 2.03% |
34,848
+21,187
| +155% | +$807K |
2022 Q2
1 quarter
|
|
13
Iovance Biotherapeutics
IOVA
$3.84B
| $907K | 1.85% |
94,650
-21,220
| -18% | -$245K |
2021 Q2
5 quarters
|
|
14
ASML
ASML
$604B
| $880K | 1.8% |
2,120
+1,300
| +159% | +$651K |
2022 Q2
1 quarter
|
|
15
Blackstone
BX
$94.6B
| $838K | 1.71% |
10,000
| – | – |
2022 Q1
2 quarters
|
|
16
Advanced Micro Devices
AMD
$824B
| $782K | 1.6% |
12,342
-6,191
| -33% | -$527K |
2022 Q1
2 quarters
|
|
17
Adobe
ADBE
$97.4B
| $779K | 1.59% |
2,831
+1,215
| +75% | +$460K |
2022 Q2
1 quarter
|
|
18
D.R. Horton
DHI
$39.6B
| $727K | 1.49% |
10,783
+84
| +0.8% | +$6.18K |
2020 Q1
10 quarters
|
|
19
DaVita
DVA
$11.8B
| $727K | 1.49% |
+8,790
| New | +$771K |
2022 Q3
0 quarters
|
|
20
Applied Materials
AMAT
$310B
| $717K | 1.47% |
8,752
-4,861
| -36% | -$469K |
2020 Q4
7 quarters
|
|
21
Meta Platforms (Facebook)
META
$1.6T
| $715K | 1.46% |
5,272
-6,522
| -55% | -$1.06M |
2020 Q1
10 quarters
|
|
22
PayPal
PYPL
$47.4B
| $655K | 1.34% |
+7,604
| New | +$674K |
2022 Q3
0 quarters
|
|
23
Somnigroup International
SGI
$14.6B
| $655K | 1.34% |
+27,070
| New | +$701K |
2022 Q3
0 quarters
|
|
24
Salesforce
CRM
$189B
| $643K | 1.31% |
+4,465
| New | +$757K |
2022 Q3
0 quarters
|
|
25
Capital One
COF
$126B
| $637K | 1.3% |
+6,910
| New | +$736K |
2022 Q3
0 quarters
|
|
Similar funds
KC
Parametrica Management's Q3 2022 Portfolio in Review
As of Q3 2022, Parametrica Management held 193 positions worth $48.9M, down 47% from $91.9M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Parametrica Management withdrew a net $39.6M in Q3 2022, closing 127 positions and reducing 23 holdings. Its most notable exit was Li Auto, an estimated $2.35M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 18% a quarter earlier, followed by Healthcare and Miscellaneous.
Against the trend, Parametrica Management opened a new position in iShares Biotechnology ETF worth $3.46M.
- Parametrica Management's largest Q3 2022 buy was iShares Biotechnology ETF: 29,500 shares worth $3.46M.
- Parametrica Management added most to Wolfspeed in Q3 2022, an estimated $1.19M increase.
- Parametrica Management's biggest Q3 2022 reduction was Pfizer, cutting an estimated $4.3M.
- Parametrica Management fully exited Li Auto in Q3 2022, selling an estimated $2.35M.
- Parametrica Management's ten largest holdings make up 55% of its $48.9M portfolio in Q3 2022.
- Parametrica Management opened 27 new positions and closed 127 in Q3 2022.
- Parametrica Management's portfolio value fell 47% quarter-over-quarter to $48.9M.
Based on Parametrica Management's 13F filing for Q3 2022, filed 3 Nov 2022.